Sept 20 (Reuters) – Beijing Beilu Pharmaceutical Co Ltd : * SAYS BIMATOPROST OPHTHALMIC SOLUTION RECEIVES NMPA'S DRUG REGISTRATION CERTIFICATE Source text Further company coverage: (Reporting by Hong
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Galaxy, Real Salt Lake set for high-stakes Decision Day
In an MLS Decision Day match that has playoff implications on both sides, the Los…
Trump administration scraps meeting of high-profile tech panel
By Courtney Rozen WASHINGTON, Nov 6 (Reuters) - The Trump administration canceled a meeting on…
Berkshire Hathaway accelerates stock buybacks, operating profit falls
By Jonathan Stempel Nov 7 (Reuters) - Berkshire Hathaway accelerated stock repurchases in the third…
